| 000 | 01728 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250515023900.0 | ||
| 264 | 0 | _c20060731 | |
| 008 | 200607s 0 0 eng d | ||
| 022 | _a0300-0664 | ||
| 024 | 7 |
_a10.1111/j.1365-2265.2006.02510.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSonmez, Alper | |
| 245 | 0 | 0 |
_aThe effect of fluvastatin on plasma adiponectin levels in dyslipidaemia. _h[electronic resource] |
| 260 |
_bClinical endocrinology _cMay 2006 |
||
| 300 |
_a567-72 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAdiponectin _xblood |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnticholesteremic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aBlood Glucose _xanalysis |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 |
_aCholesterol _xblood |
| 650 | 0 | 4 |
_aCholesterol, LDL _xblood |
| 650 | 0 | 4 |
_aDyslipidemias _xblood |
| 650 | 0 | 4 |
_aFatty Acids, Monounsaturated _xtherapeutic use |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFluvastatin |
| 650 | 0 | 4 | _aHomeostasis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIndoles _xtherapeutic use |
| 650 | 0 | 4 |
_aInsulin _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aStatistics, Nonparametric |
| 650 | 0 | 4 |
_aTriglycerides _xblood |
| 700 | 1 | _aDogru, Teoman | |
| 700 | 1 | _aTasci, Ilker | |
| 700 | 1 | _aYilmaz, M Ilker | |
| 700 | 1 | _aPinar, Murat | |
| 700 | 1 | _aNaharci, Ilkin | |
| 700 | 1 | _aBingol, Necati | |
| 700 | 1 | _aKilic, Selim | |
| 700 | 1 | _aDemirtas, Ayla | |
| 700 | 1 | _aBingol, Sezin | |
| 700 | 1 | _aOzgurtas, Taner | |
| 700 | 1 | _aErikci, Selahattin | |
| 773 | 0 |
_tClinical endocrinology _gvol. 64 _gno. 5 _gp. 567-72 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2265.2006.02510.x _zAvailable from publisher's website |
| 999 |
_c16252203 _d16252203 |
||